Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis
Fundacion Clinic per a la Recerca Biomédica
360 participants
Aug 17, 2022
INTERVENTIONAL
Conditions
Summary
Non-inferiority trial to determine whether partial oral treatment is non-inferior to OPAT(Outpatient parenteral therapy) in patients diagnosed with infective endocarditis
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
cefaclor intravenous 2 gr/day
500-750 mg/12 hrs (maximum 3g x day)
1200 mg/day maximum dose IV
600 mg/8 hours (maximum 1.800 mg x day)
600 mg/8 hours (maximum 1.800 mg x day) IV
1g/8 hours (maximum 4 gr day)
1g/8 hours (maximum 4 g x day) IV
0,750g/12 hours (maximum 1,5 g x day)
0,75 g/12 hours (maximum 1,5 g x day)
0.5g/12-24hours (maximum 1 g x day)
0.5g/12-24hours (maximum 1 g x day)
0,6 g/12 hours (maximum 1200 mg x day)
0,6 g/12 hours (maximum 1200 mg x day)
0,4 g/day (maximum 400 mg x day)
0,4 g/day (maximum 400 mg x day)
0,3-0,5 g/12 hours (maximum 1200 mg x day)
0,3-0,6 g/12 hours (maximum 1200 mg x day)
sulfamethoxazole 1600 mg/trimethoprin 320 mg (maximum x day)
sulfamethoxazole 1600 mg/trimethoprin 320 mg (maximum x day)
200 mg tedizolid (maximum x day)
200 mg (maximum x day)
1 gr/6 hours (4 g x day)
1 gr/6 hours (4 g x day) Intravenous
2 gr/day
Locations(20)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05398679